here, you can read about their clinical phase I/II study. 22 patients will be treated, they allready now got significant immune response in 7 of 8 patients. The 8th patient responded but not yet significantly.
http://www.rhovac.com/positive-immune-monitoring-results-demonstrated-companys-cancer-vaccine-rv001/
"RhoVac AB (“RhoVac”) announced today, 13 December 2017 that the company has obtained positive INFγ ELIspot results showing that seven out of eight patients tested, respond to the RV001 vaccine and mount a significant vaccine mediated immune response."
